Pharmacodiagnostics is swiftly emerging as a vital player in the global cancer diagnostics market, which soared to nearly $10 billion in revenue in 2024, according to Kalorama Information’s recent report, The World Market for Cancer Diagnostics, 2024-2029. This dynamic sub-segment is experiencing rapid growth, fueled by the increasing affordability of next-generation sequencing (NGS), which offers profound […]
Histology and cytology, foundational pillars of pathological labs, play a critical role in diagnosing a variety of diseases, including cancer. With innovations enhancing diagnostic accuracy, efficiency, and patient outcomes, the industry is poised for significant growth and transformation in the coming years. In the report, Histology and Cytology IVD Market Update, 2024, Kalorama Information’s research […]
Each year, tens of thousands of men succumb to prostate cancer, a disease with an almost 100% survival rate when diagnosed early. According to a recent article by Fortune, rates of prostate cancer, America’s second-deadliest cancer in men, are on the rise. Since 2014, the U.S. has seen a 3% annual increase in diagnoses of […]
Cancer by the Numbers There have been notable advances in cancer treatment, yet cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry, according to World Cancer Research Fund International data cited by Kalorama Information in the report Precision Cancer Therapeutics […]
Whether affecting the lungs, colorectal system, stomach, liver, breasts, or other parts of the body, few medical maladies carry the inherent gravitas of cancer. Annually, millions of new cancer cases are diagnosed and millions of cancer linked deaths occur worldwide. Undoubtedly, cancer poses one of the greatest threats to human health globally. This proliferating […]
Cell and gene therapies are trending as groundbreaking treatments with the potential to actually cure disease rather than simply manage symptoms. As a result, through 2030, the global market for cell and gene therapy is forecast to expand strongly to $29,960 million, up from $3,866 million in 2020, according to a 2021 report by Kalorama […]
